M. Müller

发表

Effect of Cardiopulmonary Bypass on Regional Antibiotic Penetration into Lung Tissue

M. Zeitlinger, E. Tschernko, W. Wisser, 2013, Antimicrobial Agents and Chemotherapy.

Acute effects of anticonvulsant drugs on gonadotropin-stimulated and precursor-supported androgen production in the rat testis.

A. Herzog, W. Kühn‐Velten, M. Müller, 1990, European journal of pharmacology.

Inhibition of paracrine angiotensin‐converting enzyme in vivo: effects on interstitial glucose and lactate concentrations in human skeletal muscle

P. Fasching, H. Eichler, W. Waldhäusl, 1997, European journal of clinical investigation.

Ragaglitazar: the pharmacokinetics, pharmacodynamics, and tolerability of a novel dual PPAR alpha and gamma agonist in healthy subjects and patients with type 2 diabetes.

P. Drake, G. Pabst, B. Edsberg, 2003, Journal of clinical pharmacology.

5-fluorouracil kinetics in the interstitial tumor space: clinical response in breast cancer patients.

T. Helbich, H. Eichler, M. Gnant, 1997, Cancer research.

Application of microdialysis to clinical pharmacokinetics in humans

H. Eichler, A. Georgopoulos, R. Schmid, 1995, Clinical pharmacology and therapeutics.

Adverse events during treatment with high-dose intravenous immunoglobulins for neurological disorders.

M. Stangel, P. Marx, M. Müller, 1998, European neurology.

Blood, Tissue, and Intracellular Concentrations of Azithromycin during and after End of Therapy

M. Kinzig, S. Hüttner, F. Sörgel, 2013, Antimicrobial Agents and Chemotherapy.

Simultaneous assessment of the pharmacokinetics of a pleuromutilin, lefamulin, in plasma, soft tissues and pulmonary epithelial lining fluid.

M. Zeitlinger, W. Prince, P. Matzneller, 2016, The Journal of antimicrobial chemotherapy.

Low-dose prednisolone has a CD4-stabilizing effect in pre-treated HIV-patients during structured therapy interruptions (STI).

M. Müller, A. Ulmer, B. Bertisch-Möllenhoff, 2005, European journal of medical research.

Low dose prednisolone reduces CD4+ T cell loss in therapy-naive HIV-patients without antiretroviral therapy.

M. Müller, A. Ulmer, B. Bertisch-Möllenhoff, 2005, European journal of medical research.

Direct assessment of peripheral pharmacokinetics in humans: comparison between cantharides blister fluid sampling, in vivo microdialysis and saliva sampling.

H. Eichler, M. Brunner, Markus Müller, 1998, British journal of clinical pharmacology.

Interstitial methotrexate kinetics in primary breast cancer lesions.

H. Eichler, G. Steger, R. Mader, 1998, Cancer research.

Ragaglitazar: The Pharmacokinetics, Pharmacodynamics, and Tolerability of a Novel Dual PPARα and γ Agonist in Healthy Subjects and Patients with Type 2 Diabetes

P. Drake, G. Pabst, B. Edsberg, 2003 .

Current concepts in pharmacokinetics and their implications for clinical medicine.

H. Derendorf, G. Hochhaus, M. Müller, 2001, Wiener klinische Wochenschrift.

Comparison of three different experimental methods for the assessment of peripheral compartment pharmacokinetics in humans.

H. Eichler, M. Brunner, I. Wallner, 1998, Life sciences.

First‐pass uptake of methotrexate after intra‐arterial bolus injection in human head and neck cancers

G. Zanaschka, H. Eichler, W. Millesi, 1996, European journal of clinical investigation.

Cisplatin‐induced renal effects and thromboxane A2 receptor blockade

H. Pehamberger, M. Wolzt, H. Eichler, 1997, European journal of clinical investigation.

Effects of cisplatin on urinary thromboxane B2 excretion

H. Pehamberger, H. Eichler, P. Kyrle, 1995, Clinical pharmacology and therapeutics.

GW420867X Administered to HIV-1-Infected Patients Alone and in Combination with Lamivudine and Zidovudine

R. Wood, W. Prince, A. Jones, 2001, HIV clinical trials.

Pharmacokinetics of physostigmine in man following a single application of a transdermal system.

A. Nieciecki, K. Walter, M. Müller, 1995, British journal of clinical pharmacology.

Impact of plasma protein binding on antimicrobial activity using time-killing curves.

M. Zeitlinger, A. Georgopoulos, R. Sauermann, 2004, The Journal of antimicrobial chemotherapy.

Characterization of peripheral-compartment kinetics of antibiotics by in vivo microdialysis in humans

H. Pehamberger, H. Eichler, W. Weninger, 1996, Antimicrobial agents and chemotherapy.

Penetration of Fosfomycin into Inflammatory Lesions in Patients with Cellulitis or Diabetic Foot Syndrome

F. Legat, W. Salmhofer, P. Dittrich, 2003, Antimicrobial Agents and Chemotherapy.

Target site bacterial killing of cefpirome and fosfomycin in critically ill patients.

M. Zeitlinger, A. Georgopoulos, M. Müller, 2003, International journal of antimicrobial agents.

Microdialysis in clinical drug delivery studies.

M. Müller, M. Müller, 2000, Advanced drug delivery reviews.

Plasma concentrations might lead to overestimation of target site activity of piperacillin in patients with sepsis.

M. Zeitlinger, A. Georgopoulos, B. Erovic, 2005, The Journal of antimicrobial chemotherapy.

Angioplasty increases target site concentrations of ciprofloxacin in patients with peripheral arterial occlusive disease

E. Minar, N. Klein, M. Müller, 2001, Clinical pharmacology and therapeutics.

Two years of experience in the treatment of status epilepticus with intravenous levetiracetam

M. Müller, M. Grumbt, S. Eue, 2009, Epilepsy & Behavior.

Single daily doses of saquinavir achieve HIV-inhibitory concentrations when combined with baby-dose ritonavir.

M. Kurowski, F. Donath, M. Mrozikiewicz, 1999, European journal of medical research.

Use of Saliva Specimens for Monitoring Indinavir Therapy in Human Immunodeficiency Virus-Infected Patients

M. Kurowski, E. Wolf, M. Müller, 2000, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics of Single Ascending Doses of the P-Glycoprotein Inhibitor Tariquidar in Healthy Subjects

W. Jäger, M. Zeitlinger, O. Langer, 2012, Pharmacology.

HES 130/0.4, a new HES specification: pharmacokinetics after multiple infusions of 10% solutions in healthy volunteers

J. Waitzinger, F. Bepperling, G. Pabst, 2000, Critical Care.

Gastrointestinal transit and release of 5‐aminosalicylic acid from 153Sm‐labelled mesalazine pellets vs. tablets in male healthy volunteers

H. Eichler, M. Brunner, R. Greinwald, 2003, Alimentary pharmacology & therapeutics.

Colonic spread and serum pharmacokinetics of budesonide foam in patients with mildly to moderately active ulcerative colitis

H. Eichler, C. Schrolnberger, M. Brunner, 2005, Alimentary pharmacology & therapeutics.

Gastrointestinal transit and 5‐ASA release from a new mesalazine extended‐release formulation

H. Eichler, M. Brunner, M. Müller, 2003, Alimentary pharmacology & therapeutics.

Transdermal penetration of diclofenac after multiple epicutaneous administration.

H. Eichler, B. Jansen, P. Ferri, 1998, Journal of Rheumatology.

Gastrointestinal transit, release and plasma pharmacokinetics of a new oral budesonide formulation.

M. Brunner, R. Dudczak, G. Celasco, 2006, British journal of clinical pharmacology.

5‐aminosalicylic acid release from a new controlled‐release mesalazine formulation during gastrointestinal transit in healthy volunteers

H. Eichler, M. Brunner, R. Dudczak, 2006, Alimentary pharmacology & therapeutics.

Relevance of Soft-Tissue Penetration by Levofloxacin for Target Site Bacterial Killing in Patients with Sepsis

M. Zeitlinger, A. Georgopoulos, M. Müller, 2003, Antimicrobial Agents and Chemotherapy.

Drug monitoring of quinine by HPLC in cerebral malaria with acute renal failure treated by haemofiltration

T. Risler, G. Ehninger, B. Proksch, 2004, European Journal of Clinical Pharmacology.

Access of HTB, main metabolite of triflusal, to cerebrospinal fluid in healthy volunteers

I. Izquierdo, H. Eichler, A. Donner, 2005, European Journal of Clinical Pharmacology.

Microdialysis. A novel tool for clinical studies of anti-infective agents.

H. Derendorf, C. Joukhadar, M. Müller, 2001, European journal of clinical pharmacology.

Pharmacokinetics and pharmacodynamics of the novel H1-receptor antagonist emedastine in healthy volunteers

B. Jansen, V. Wacheck, A. Assandri, 2000, European Journal of Clinical Pharmacology.

Pharmacokinetic and mass balance study of unlabelled and 14 C-labelled emedastine difumarate in healthy volunteers

H. Eichler, M. Brunner, A. Assandri, 2002, Xenobiotica; the fate of foreign compounds in biological systems.

Disposition and Metabolism of Ralfinamide, a Novel Na-Channel Blocker, in Healthy Male Volunteers

M. Brunner, C. Leuratti, E. Lackner, 2010, Pharmacology.

Pgp‐Mediated Interaction Between (R)‐[11C]Verapamil and Tariquidar at the Human Blood–Brain Barrier: A Comparison With Rat Data

Oliver Langer, C Kuntner, W. Löscher, 2012, Clinical pharmacology and therapeutics.

Steady state investigation of possible pharmacokinetic interactions of moxonidine and glibenclamide

G. Achtert, W. Weber, H. Weimann, 1993, European Journal of Drug Metabolism and Pharmacokinetics.

Influence of food on the oral bioavailability of moxonidine

W. Weber, H. Weimann, M. Müller, 2010, European Journal of Drug Metabolism and Pharmacokinetics.

Pharmacokinetics of levormeloxifene in young versus elderly postmenopausal women.

B. Kiehr, B. Skrumsager, M. Müller, 2001, Clinical therapeutics.

Using Positron Emission Tomography to Study Transporter-Mediated Drug–Drug Interactions in Tissues

M. Zeitlinger, O. Langer, M. Bauer, 2014, Clinical pharmacology and therapeutics.

[In vivo verification of in vitro release specifications of a theophylline sustained-release preparation].

S. Gay, A. Laicher, G. Pabst, 1998, Arzneimittel-Forschung.

Plasma pharmacokinetics of desmopressin following sublingual administration: an exploratory dose-escalation study in healthy male volunteers.

S. Kaehler, R. Sauermann, C. Joukhadar, 2006, International journal of clinical pharmacology and therapeutics.

A combined in vivo pharmacokinetic-in vitro pharmacodynamic approach to simulate target site pharmacodynamics of antibiotics in humans.

H Derendorf, S. Hofmann, H. Eichler, 2000, The Journal of antimicrobial chemotherapy.

Pharmacokinetics of the local anesthetic ropivacaine after transversus abdominis plane block in healthy volunteers

M. Zeitlinger, P. Marhofer, R. Sauermann, 2012, European Journal of Clinical Pharmacology.

Key metabolite kinetics in human skeletal muscle during ischaemia and reperfusion: measurement by microdialysis

P. Fasching, H. Eichler, P. Lönnroth, 1995, European journal of clinical investigation.